Earnings Preview: AptarGroup (ATR) Q4 Earnings Expected to DeclineZacks Investment Research • 01/29/26
Aptar Again Recognized with Prestigious ‘A' Score on the CDP Climate Change AssessmentBusiness Wire • 01/21/26
AptarGroup, Inc. (ATR) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/14/26
Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026Business Wire • 01/05/26
Aptar's Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)Business Wire • 12/17/25
Aptar Named One of America's Most Responsible Companies by Newsweek for the Seventh Consecutive YearBusiness Wire • 12/04/25
AptarGroup, Inc. (ATR) Presents at Jefferies London Healthcare Conference 2025 TranscriptSeeking Alpha • 11/19/25
Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025Business Wire • 11/11/25
Compared to Estimates, AptarGroup (ATR) Q3 Earnings: A Look at Key MetricsZacks Investment Research • 10/31/25
5 Containers - Paper and Packaging Stocks to Watch in a Promising IndustryZacks Investment Research • 10/27/25
AptarGroup (ATR) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 10/23/25
AptarGroup Rewards Shareholders With 7% Hike in Quarterly DividendZacks Investment Research • 09/09/25